ICD-10 Code for Polyneuropathy

Main code

G62.9 – Polyneuropathy, unspecified

Billable

Yes

Index entries for Polyneuropathy

• alcoholic – G62.1
• amyloid (Portuguese) – E85.1 – G63 [manifestation]
  • transthyretin-related (ATTR) – E85.1 – G63 [manifestation]
• arsenical – G62.2
• critical illness – G62.81
• demyelinating, chronic inflammatory (CIDP) – G61.81
• diabetic – see Diabetes, polyneuropathy
• drug-induced – G62.0
• hereditary – G60.9
  • specified NEC – G60.8
• idiopathic – G60.9
  • progressive – G60.3
• in (due to)
  • alcohol – G62.1
    • sequelae – G65.2
  • amyloidosis, familial (Portuguese) – E85.1 – G63 [manifestation]
  • antitetanus serum – G61.1
  • arsenic – G62.2
    • sequelae – G65.2
  • avitaminosis NEC – E56.9 – G63 [manifestation]
  • beriberi – E51.11
  • collagen vascular disease NEC – M35.9 – G63 [manifestation]
  • deficiency (of)
    • B (-complex) – E53.9 – G63 [manifestation]
    • vitamin B6 – E53.1 – G63 [manifestation]
  • diabetes – see Diabetes, polyneuropathy
  • diphtheria – A36.83
  • drug or medicament – G62.0
    • correct substance properly administered – see Table of Drugs and Chemicals, by drug, adverse effect
    • overdose or wrong substance given or taken – see Table of Drugs and Chemicals, by drug, poisoning
  • endocrine disease NEC – E34.9 – G63 [manifestation]
  • herpes zoster – B02.23
  • hypoglycemia – E16.2 – G63 [manifestation]
  • infectious
    • disease NEC – B99 (header) – G63 [manifestation]
    • mononucleosis – B27.91
  • lack of vitamin NEC – E56.9 – G63 [manifestation]
  • lead – G62.2
    • sequelae – G65.2
  • leprosy – A30.9 – G63 [manifestation]
  • Lyme disease – A69.22
  • metabolic disease NEC – E88.9 – G63 [manifestation]
  • microscopic polyangiitis – M31.7 – G63 [manifestation]
  • mumps – B26.84
  • neoplastic disease – D49.9 – G63 [manifestation] – see also Neoplasm
  • nutritional deficiency NEC – E63.9 – G63 [manifestation]
  • organophosphate compounds – G62.2
    • sequelae – G65.2
  • parasitic disease NEC – B89 – G63 [manifestation]
  • pellagra – E52 – G63 [manifestation]
  • polyarteritis nodosa – M30.0
  • porphyria – E80.20 – G63 [manifestation]
  • radiation – G62.82
  • rheumatoid arthritis – see Rheumatoid, polyneuropathy
  • sarcoidosis – D86.89
  • serum – G61.1
  • syphilis (late) – A52.15
    • congenital – A50.43
  • systemic
    • connective tissue disorder – M35.9 – G63 [manifestation]
    • lupus erythematosus – M32.19
  • toxic agent NEC – G62.2
    • sequelae – G65.2
  • transthyretin-related (ATTR) – E85.1
  • triorthocresyl phosphate – G62.2
    • sequelae – G65.2
  • tuberculosis – A17.89
  • uremia – N18.9 – G63 [manifestation]
  • vitamin B12 deficiency – E53.8 – G63 [manifestation]
    • with anemia (pernicious) – D51.0 – G63 [manifestation]
      • due to dietary deficiency – D51.3 – G63 [manifestation]
  • zoster – B02.23
• inflammatory – G61.9
  • chronic demyelinating (CIDP) – G61.81
  • sequelae – G65.1
  • specified NEC – G61.89
• lead – G62.2
  • sequelae – G65.2
• nutritional NEC – E63.9 – G63 [manifestation]
• postherpetic (zoster) – B02.23
• progressive – G60.3
• radiation-induced – G62.82
• sensory (hereditary) (idiopathic) – G60.8
• specified NEC – G62.89
• syphilitic (late) – A52.15
  • congenital – A50.43